Transaction | Address | Amount |
---|---|---|
10d676...eda8c2
|
TUqf2Z...J1PVbR
|
-
0.345 TRX
·
0.05 USD
|
10d676...eda8c2
|
the-void |
+
0.345 TRX
·
0.05 USD
|
10d676...eda8c2
|
TUqf2Z...J1PVbR
|
-
0 TRX
·
0.00 USD
|
10d676...eda8c2
|
TR7NHq...gjLj6t
|
+
0 TRX
·
0.00 USD
|
28de61...5493ee
|
TQ7pyg...k7Csm7
|
-
0 TRX
·
0.00 USD
|
28de61...5493ee
|
TSajhk...4NmcaE
|
+
0 TRX
·
0.00 USD
|
b70577...882ed1
|
TR3Wte...b1Zikg
|
-
0 TRX
·
0.00 USD
|
b70577...882ed1
|
TR7NHq...gjLj6t
|
+
0 TRX
·
0.00 USD
|
6254fc...574f7c
|
TFVduG...EEReEB
|
-
0.000001 TRX
·
0.00 USD
|
6254fc...574f7c
|
TBZfn9...VshjTe
|
+
0.000001 TRX
·
0.00 USD
|
Tron Inc. shifts focus to a TRX-centered crypto treasury, registering $1 billion in securities.
Tron plans a $1 billion SEC filing, including a shelf registration. Here's why it matters.
Injective (INJ) targets $25 amid a bullish breakout attempt, hitting a five-month high of $16.35. Analysts predict a significant rally if key resistance levels are reclaimed. Still, failure to hold above certain thresholds might send prices down.